A detailed history of Sanders Morris Harris LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Sanders Morris Harris LLC holds 12,372 shares of AZN stock, worth $808,510. This represents 0.16% of its overall portfolio holdings.

Number of Shares
12,372
Previous 12,372 -0.0%
Holding current value
$808,510
Previous $964,000 -0.0%
% of portfolio
0.16%
Previous 0.16%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

BUY
$61.03 - $69.57 $33,566 - $38,263
550 Added 4.65%
12,372 $838,000
Q4 2023

Jan 10, 2024

SELL
$61.89 - $69.28 $34,039 - $38,104
-550 Reduced 4.45%
11,822 $796,000
Q3 2023

Oct 13, 2023

BUY
$64.85 - $71.7 $802,324 - $887,072
12,372 New
12,372 $837,000
Q2 2023

Jul 10, 2023

BUY
$69.91 - $75.81 $864,926 - $937,921
12,372 New
12,372 $885,000
Q3 2021

Oct 13, 2021

SELL
$55.56 - $60.79 $527,820 - $577,505
-9,500 Closed
0 $0
Q1 2021

Apr 19, 2021

BUY
$47.16 - $54.44 $448,019 - $517,180
9,500 New
9,500 $472,000
Q1 2021

Apr 14, 2021

SELL
$47.16 - $54.44 $641,376 - $740,384
-13,600 Closed
0 $0
Q3 2020

Oct 16, 2020

BUY
$53.07 - $61.1 $102,425 - $117,923
1,930 Added 16.54%
13,600 $744,000
Q2 2020

Jul 09, 2020

BUY
$43.1 - $55.31 $502,977 - $645,467
11,670 New
11,670 $618,000
Q1 2020

Apr 09, 2020

SELL
$37.79 - $51.33 $423,248 - $574,896
-11,200 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$40.12 - $45.47 $88,264 - $100,034
2,200 Added 24.44%
11,200 $494,000
Q3 2018

Oct 10, 2018

BUY
$34.76 - $39.72 $300,465 - $343,339
8,644 Added 2428.09%
9,000 $356,000
Q3 2018

Oct 09, 2018

SELL
$34.76 - $39.72 $300,465 - $343,339
-8,644 Reduced 96.04%
356 $356,000
Q3 2017

Oct 23, 2017

BUY
$28.96 - $34.0 $260,640 - $306,000
9,000
9,000 $305,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Sanders Morris Harris LLC Portfolio

Follow Sanders Morris Harris LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sanders Morris Harris LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sanders Morris Harris LLC with notifications on news.